Case Study:
Faster Time to Reimbursement
How to Use AI for Faster Time to Reimbursement
According to Pharmaceutic Executive, a delay in launch can cost a company an average of $15 million per drug, per day. This project was about using Artificial Intelligence to speed up the time to reimbursement on different formularies after FDA approval.
The Client Problem
Thee client analysed how many $ were left on the table with every day delay to reimbursement approval in different formularies. They wanted to see if Artificial Intelligence could impact this positively and speed up time to reimbursement thereby increasing revenue from their products.
The Solution
Using a combination of different AI techniques, to:
- identify the factors affecting time-to-reimbursement for newly launched medicines post market approval,
- provide insight into what to include in, or leave out of submissions for formulary inclusion
- find other important considerations and insights that have worked in the past to accelerate time-to-reimbursement.
The Outcome
Reimbursement was achieved much faster in the pilot of formularies using AI versus the ones not using AI. The average improvement in speed was 6 weeks. At an average of $15 m/day that can be left on the table, the amount of revenue gained from this simple increase in speed to reimbursement allowed a significant return on investment and the approach is now being rolled out to other products as well.
To achieve these kinds of results, contact Eularis today.

Latest Blogs
Check out our latest blogs

How Artificial Intelligence revolutionizes the management of Rare Diseases
Rare diseases develop complex problems in healthcare systems. The world’s 7,000-8,000 rare diseases collectively affect more than 300 million people globally although each disease affects

How to Overcome AI Resistance in Your Organization
In the crucible of modern drug development—where a single molecule’s journey from lab to patient spans an average of 12 years and $2.3 billion—AI has emerged

CRO 2.0: Transforming Tomorrow’s Clinical Research Process with Artificial Intelligence
The clinical trial ecosystem—a $90 billion engine driving medical innovation—is struggling under the burden of its own complexity. Despite significant advancements in therapeutic science, a